|
Real-time Estimate
Cboe BZX
21:29:54 17/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.4725 USD | -4.69% |
|
-15.18% | -64.44% |
| 03:28pm | Maxim Group Downgrades cbdMD to Hold From Buy | MT |
| 08-14 | CbdMD, Inc., Q3 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 5.2M 4.49M 4.22M 3.84M 7.22M 498M 7.32M 49.41M 19.36M 249M 19.54M 19.12M 829M | P/E 2026 * |
-1.5x | P/E 2027 * | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 5.2M 4.49M 4.22M 3.84M 7.22M 498M 7.32M 49.41M 19.36M 249M 19.54M 19.12M 829M | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.23x |
| Free-Float |
83.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: cbdMD, Inc.
| 1 day | -3.16% | ||
| 1 week | -15.18% | ||
| Current month | -5.29% | ||
| 1 month | -15.76% | ||
| 3 months | -37.65% | ||
| 6 months | -38.16% | ||
| Current year | -64.44% |
| 1 week | 0.48 |  | 0.62 |
| 1 month | 0.46 | | 0.62 |
| Current year | 0.46 | | 1.34 |
| 1 year | 0.46 | | 2.56 |
| 3 years | 0.46 | | 13.84 |
| 5 years | 0.46 | | 882 |
| 10 years | 0.46 | | 2,606.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
T. Kennedy
CEO | Chief Executive Officer | 47 | 01/03/2023 |
Zeb Booker
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2019 |
Sibyl Swift
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bakari Sellers
BRD | Director/Board Member | 41 | 01/03/2017 |
William Raines
BRD | Director/Board Member | 66 | 19/04/2019 |
Scott Stephen
CHM | Chairman | 60 | 03/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 A | Crc Investment Fund LP
| Sell | Company | 550,701 | 6.1787% | |
| 11/28/25 A | Free | Chief Executive Officer | 445,000 | 4.9927% | ||
| 5/16/25 A | Free | Chairman | 1,572 | 0.0251% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.69% | -15.18% | -29.40% | -95.16% | 5.2M | |
| +1.12% | -3.23% | +70.78% | +121.73% | 1,052B | |
| +0.80% | +0.23% | +48.89% | +50.80% | 627B | |
| +0.38% | +0.96% | +21.19% | +66.87% | 441B | |
| +0.28% | -4.56% | +39.10% | +38.05% | 349B | |
| +0.78% | -2.68% | +23.13% | +37.32% | 287B | |
| +0.87% | -3.59% | -1.52% | +7.12% | 241B | |
| +0.25% | -0.23% | +42.24% | +57.75% | 224B | |
| -0.78% | -4.49% | -15.86% | -54.13% | 202B | |
| +0.38% | +4.39% | +17.72% | +81.57% | 172B | |
| Average | -0.02% | -1.92% | +21.63% | +31.19% | 359.52B | |
| Weighted average by Cap. | +0.55% | -0.63% | +39.98% | +64.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.15M 19.12M 17.94M 16.34M 30.73M 2.12B 31.15M 210M 82.42M 1.06B 83.17M 81.37M 3.53B | 23.26M 20.08M 18.84M 17.16M 32.26M 2.22B 32.71M 221M 86.54M 1.11B 87.33M 85.44M 3.71B |
| Net income | -1.9M -1.64M -1.54M -1.4M -2.64M -182M -2.67M -18.06M -7.08M -91.11M -7.14M -6.99M -303M | -902K -779K -731K -665K -1.25M -86.24M -1.27M -8.56M -3.36M -43.21M -3.39M -3.31M -144M |
| Net Debt | - | - |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | $0.4801 | -3.16% | 77,293 |
| 14/08/26 | $0.4958 | -12.26% | 496,992 |
| 13/08/26 | $0.5650 | -5.52% | 223,647 |
| 12/08/26 | $0.5980 | +2.22% | 203,054 |
| 11/08/26 | $0.5850 | +3.36% | 175,854 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.4958USD
Average target price
2.000USD
Spread / Average Target
+303.43%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YCBD Stock
Select your edition
All financial news and data tailored to specific country editions
